Particulate matter (PM) air pollution exposure has been associated with cancer incidence and mortality especially with lung cancer. The liver is another organ possibly affected by PM due to its role in detoxifying xenobiotics absorbed from PM. Various studies have investigated the mechanistic pathways between inhaled pollutants and liver damage, cancer incidence, and tumor progression. However, little is known about the effects of PM on liver cancer survival. Twenty thousand, two hundred and twenty-one California Cancer Registry patients with hepatocellular carcinoma (HCC) diagnosed between 2000 and 2009 were used to examine the effect of exposure to ambient PM with diameter <2.5 lm (PM 2.5 ) on HCC survival. Cox proportional hazards models were used to estimate hazard ratios (HRs) relating PM 2.5 to all-cause and liver cancer-specific mortality linearly and nonlinearly-overall and stratified by stage at diagnosis (local, regional and distant)-adjusting for potential individual and geospatial confounders. PM 2.5 exposure after diagnosis was statistically significantly associated with HCC survival. After adjustment for potential confounders, the all-cause mortality HR associated with a 1 standard deviation (5.0 mg/m 3 ) increase in PM 2.5 was 1.18 (95% CI: 1.16-1.20); 1.31 (95% CI:1.26-1.35) for local stage, 1.19 (95% CI:1.14-1.23) for regional stage, and 1.05 (95% CI:1.01-1.10) for distant stage. These associations were nonlinear, with substantially larger HRs at higher exposures. The associations between liver cancer-specific mortality and PM 2.5 were slightly attenuated compared to all-cause mortality, but with the same patterns. Exposure to elevated PM 2.5 after the diagnosis of HCC may shorten survival, with larger effects at higher concentrations.
Air pollution is classified as a carcinogen by the International Agency for Research on Cancer (IARC). 1 While associations between ambient particulate matter with diameter <2.5 lm (PM 2.5 ) and lung cancer have been well documented, associations with cancers at other sites have received less attention. 2 The liver may be a target as PM 2.5 can induce oxidative stress, inflammation, genotoxicity, and accelerate liver inflammation and steatosis, driving the development and progression of liver cancer. 3 For example, PM 2.5 exposure has been linked to increased serum levels of hepatic enzymes such as alanine aminotransferase, which is a marker of liver damage and a predictor of hepatocellular carcinoma (HCC), the most common liver cancer. 4 Long-term PM 2.5 exposures have recently been linked to an increased incidence of HCC, 4 but the effects of PM 2.5 exposure on survival of HCC have not been investigated. We hypothesized that PM 2.5 exposure accelerates the progression of HCC and decreases survival after the diagnosis of liver cancer.
Material and Methods
To determine whether PM 2.5 exposure is associated with survival in liver cancer patients, we combined data on patients newly diagnosed with primary HCC (ICD-O-3 site code of C22.0 and morphology codes of 8170-8176 5 ) between 2000 and 2009 from the California Cancer Registry (CCR; http:// www.ccrcal.org) and PM 2.5 air pollution data collected by the U.S. Environmental Protection Agency's Air Quality System (AQS) database 6 for the same time period, using the same methods as described in detail in a previous study. 7 Briefly, the CCR data contain information on patient demographics, routine follow-up on vital status, tumor characteristics (including stage of diagnosis), and first course of treatment within 6 months of diagnosis for all HCC patients diagnosed in California. Cancer records were geocoded by longitude and latitude based on residential address at diagnosis, and then assigned into census tracts and block groups for assignment of area-based estimates of rural-urban commuting area (RUCA) codes and socioeconomic status (SES). Specifically, RUCA codes are census tract-level designations from 1 (metropolitan) to 10 (rural) based on the size and direction of primary commuting flows, using measures of population density, urbanization, and daily commuting (www.ers.usda.gov/ data-products/rural-urban-commuting-area-codes.aspx). 6 and spatially interpolated to residence locations from up to four closest air quality monitoring stations using inverse distancesquared weighting. 7,13 PM 2.5 exposures were not assigned to patient residences with unmatched geocodes or with the nearest monitor located > 25 km away. Survival-period exposure summaries were calculated as the average ambient residential monthly PM 2.5 from date of diagnosis to date of death or loss to follow-up or the end of study. Kaplan-Meier curves were used to calculate median survival stratified by stage at diagnosis and categorized PM 2.5 exposure. Cox proportional hazards models were used to estimate the PM 2.5 exposure (<10, 10-25 and >25 mg/m 3 ) and survival association. We considered both all-cause and liver cancer specific mortality, where liver cancer was the underlying cause of death on the death certificate (ICD-10 code C22.0-C22.9).
14 Patient survival was censored due to loss to follow-up or study end (or, for liver cancer specific mortality, censored due to death by another cause). Hazard ratios (HRs)-scaled to a standard deviation (SD) increase in PM 2.5 -were obtained from Cox models that adjusted for predetermined potential confounders: age, sex, race/ethnicity (non-Hispanic white, Hispanic, non-Hispanic black, Asian/ Pacific islanders and other/unknown), marital status (single, married, formerly married and unknown), year of diagnosis, month of diagnosis, and initial treatment (surgery, radiation, and/or chemotherapy versus none), SES, dichotomized RUCA (metropolitan core, non-metropolitan core), categorized distance to primary interstate highways and primary US and State Highways (<300, 300-1500 and >1500 m). Adjusted Cox models were stratified by tumor stage at diagnosis (local, regional and distant). Sensitivity analyses were performed by further stratifying the stage-specific Cox models by distance to monitor, geocoding accuracy (street-level matching vs. city-level matching), regions (Los Angeles county, San Francisco Bay Area, San Diego county, and other regions in California), and socioeconomic status. Nonlinear associations with PM 2.5 were examined using a natural cubic spline with 2 degrees of freedom 2 and Cox models with categorized PM 2.5 . Analyses were conducted using SAS version 9.4 (SAS Institute Inc.) and R version 3.3.1 (http://www.R-project.org). Hypothesis tests were 2-sided with a 0.05 significance level.
Results
Overall, median survival was 0.64 years and only 324 patients were lost to follow-up (i.e., not known to be dead and with a last follow-up date 15 months or longer before the study end). HCC patients were on average 63.7 years old at diagnosis, racially diverse (38.9% non-Hispanic white, 25.9% Hispanic white, 26.1% Asian/Pacific islander) and predominantly male (75.0%), and living in metropolitan core areas (90.6%; Table 1 ). The most common stage at diagnosis was local (44.8%) followed by regional (27.5%), distant (17.6%), and unknown (10.0%). The number of patients diagnosed at local stage increased from 533 (5.9%) in 2000 to 1347 (14.9%) in 2009 while the number decreased from 548 (15.4%) to 395 (11.1%) in distant stage (data not shown). The most common initial treatments were chemotherapy (32.4%) and surgery
What's new?
While the lung is a primary site of cancer caused by air pollution, other organs are also affected, including the liver, which breaks down foreign substances associated with particulate matter (PM). In this registry-based study, potential effects of air pollution exposure on liver cancer survival were examined in more than 20,000 patients newly diagnosed with hepatocellular carcinoma (HCC) from 2000 to 2009 in California. The data show that after HCC diagnosis, PM 2.5 exposure was associated with shortened survival, with adverse effects increasing with PM concentration. The results suggest that reduced exposure to high PM 2.5 levels could benefit survival in non-respiratory system cancers. S1 ). Median all-cause mortality times were higher in low PM 2.5 areas for patients diagnosed at either local or regional stage (Table 2 ). For example, median survival times for patients diagnosed at local stage living in lowest and highest PM 2.5 exposure areas were 2.16 and 0.07 years, respectively. After adjusting for potential confounders, PM 2.5 level was inversely associated with all-cause mortality with statistical significance. Allowing for nonlinear associations using splines or categorized exposure, the adjusted PM 2.5 HR for all-cause mortality were significantly higher in high exposure areas in both overall and in stage-specific models (Fig. 1, Table 2 ). In stage-specific models using a linear term for continuous PM 2.5 exposure, the HRs associated with a 1 SD increase in PM 2.5 were 1.31 (95% CI: 1.26-1.35) for local stage, 1.19 (95% CI: 1.14-1.23) for regional stage, and 1.05 (95% CI: 1.01-1.10) for distant stage. This indicates the damaging effect of PM 2.5 is most substantial for patients with local disease and diminishes with worsened stage, which likely reflects the shortened survival/exposure time for patients with late stage disease. The associations between liver cancer specific survival and exposure to PM 2.5 were slightly attenuated, but the pattern that adjusted PM 2.5 HR was larger for patients diagnosed at early stage remained (Supporting Information eTable S2). Sensitivity analyses show that stage-stratified HRs were robust to stratification by distance to monitor, geocoding accuracy, and socioeconomic status (Supporting Information eTable S3). Stratification by various metropolitan areas (LA County, San Diego County and San Francisco Bay Area) showed a consistent pattern of larger PM 2.5 HR for patients with local stage at diagnosis as compared to patients with more advanced stage at diagnosis.
Discussion
Our study provides the first evidence that exposure after HCC diagnosis to a major ambient air pollutant, PM 2.5 , is associated with shortened survival. These associations were strongest for patients diagnosed at local stage and showed larger adverse effects at higher PM 2.5 levels. To our knowledge, no study has related PM 2.5 to liver cancer survival, but several have examined other PM 2.5 -liver cancer associations. 2, 4 For instance, in a large cohort study (n 5 66,820) (between 1998 and 2001). Our study specifically targeted HCC and conducted stage-specific analysis, which limits carry-over effects at diagnosis. Our population-based study design-consisting of all Californian HCC cases between 2000 and 2009-minimizes selection and survivorship bias. California also has one of the largest and longest running air pollution monitoring networks and a wide range of PM 2.5 exposures allowing large valid scale exposure assessment using standard methods. Residential addresses were available only at the date of diagnosis, so there could be exposure misclassification due to patients relocating. However, patients with HCC were less likely to relocate after diagnosis, as the survival times were very short. An important limitation of our registry-based design is that personal-level data (e.g., alcohol consumption, Hepatitis A/B status, weight, and residential histories after diagnosis) were not available in the CCR. We did control for area-level SES and rural/urban factors, major confounders to the PM 2.5 -HCC survival associations, and believe that factors other than SES and residential location were unlikely to be associated with the spatio-temporal distribution of ambient air pollution exposures. Thus, the associations could not have spuriously induced with the adjustment of these omitted factors. Nevertheless, future studies should consider additional personallevel factors.
Previous studies have suggested exposure-response relationships for PM 2.5 that were linear for lung cancer mortality or steeply increasing at low exposure levels and flattening out at higher exposures for cardiovascular mortality. 15, 16 However, our finding of nonlinear (concave upward, quadratic curved) PM 2.5 -HCC survival associations has significant public health implications, providing evidence that relatively small reductions in high pollution levels could have substantial health impacts. However, the magnitude of the HRs at the high pollution levels were large. While these findings were plausible and consistent with the results from the analysis on the linear association, we recognize there might be unmeasured risk factors such as those personal-level confounders that are not available in our data. Future research is needed to confirm this finding. In summary, we found adverse effects of PM 2.5 exposure after diagnosis on liver cancer survival. Not only were such effects more profoundly for those diagnosed with early stage, but they also increased strongly with concentration, suggesting that reductions in high PM 2.5 exposure could increase survival for a nonrespiratory system cancer. Figure 1 . Nonlinear patterns of adjusted a associations between PM 2.5 exposure and all-cause mortality (solid line) and 95% confidence interval (dashed line) estimated using a natural cubic spline with 2 degrees of freedom. Points with confidence intervals are HRs and 95% confidence intervals for all-cause mortality from pooled and stage-specific Cox proportional hazard models with categorized PM 2.5 exposure.
b The distribution of PM 2.5 exposures are demarcated using ticks above the x-axis. . The HRs for all-cause mortality from pooled and stage-specific Cox proportional hazard models with categorized PM 2.5 exposure are presented in Table 2 
